| Fund ID | 805-3140186913 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| New Rhein Healthcare 2021 (lux) Scsp | Venture Capital | $80.2M |
| New Rhein Healthcare 2021 (de) LP | Venture Capital | $44.2M |
| New Rhein Healthcare 18 LP | Venture Capital | $42.8M |
New Rhein Healthcare 2021 Privak reports $47.2 million in gross assets, among the top 55% of private funds by size.
The stated minimum investment is $100,000.
New Rhein Healthcare 2021 Privak is managed by New Rhein Healthcare Investors LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.